2 Reasons to Like ZTS (and 1 Not So Much) [Yahoo! Finance]
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Yahoo! Finance
This may have investors wondering how to approach the situation. Given the weaker price action, is now the time to buy ZTS? Find out in our full research report, it's free Why Does Zoetis Spark Debate? Originally spun off from Pfizer in 2013 as the world's largest pure-play animal health company, Zoetis (NYSE:ZTS) discovers, develops, and sells medicines, vaccines, diagnostic products, and services for pets and livestock animals worldwide. Two Positive Attributes: 1. Constant Currency Revenue Drives Growth In addition to reported revenue, constant currency revenue is a useful data point for analyzing Branded Pharmaceuticals companies. This metric excludes currency movements, which are outside of Zoetis's control and are not indicative of underlying demand. Over the last two years, Zoetis's constant currency revenue averaged 9.1% year-on-year growth. This performance was solid and shows it can expand steadily on a global scale regardless of the macroeconomic environment.
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Zoetis to Participate in Upcoming Investor ConferencesBusiness Wire
- Zoetis (ZTS) had its "outperform" rating reaffirmed by William Blair.MarketBeat
- Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health InnovationBusiness Wire
- Zoetis Stock: Is ZTS Underperforming the Healthcare Sector? [Yahoo! Finance]Yahoo! Finance
- Zoetis (ZTS) had its "buy" rating reaffirmed by BTIG Research.MarketBeat
ZTS
Earnings
- 2/12/26 - Beat
ZTS
Sec Filings
- 2/23/26 - Form 4
- 2/23/26 - Form 4
- 2/23/26 - Form 4
- ZTS's page on the SEC website